{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T21:00:49Z","timestamp":1780174849675,"version":"3.54.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,16]],"date-time":"2027-04-16T00:00:00Z","timestamp":1807833600000},"content-version":"am","delay-in-days":258,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T35 DK072923"],"award-info":[{"award-number":["T35 DK072923"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"US Department of Defense Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["HT9425-23-1-0017"],"award-info":[{"award-number":["HT9425-23-1-0017"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014042","name":"US Department of Defense Peer Reviewed Cancer Research Program","doi-asserted-by":"publisher","award":["HT9425-23-1-0018"],"award-info":[{"award-number":["HT9425-23-1-0018"]}],"id":[{"id":"10.13039\/100014042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004802","name":"California Breast Cancer Research Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004802","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES030283"],"award-info":[{"award-number":["P30ES030283"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006438","name":"Office of the Assistant Secretary for Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbadis.2026.168266","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:14:09Z","timestamp":1776294849000},"page":"168266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells"],"prefix":"10.1016","volume":"1872","author":[{"given":"Kellianne M.","family":"Piell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vallarta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali E.","family":"Wilt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey L.","family":"Avila-Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary H.","family":"Sumlut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navya","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda J.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Clem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn M.","family":"Klinge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168266_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2026.168266_bb0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2026.168266_bb0015","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0020","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/1535-7163.MCT-23-0564","article-title":"PKMYT1 is a marker of treatment response and a therapeutic target for CDK4\/6 inhibitor-resistance in ER+ breast cancer","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2026.168266_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fendo.2019.00245","article-title":"Endocrine resistance in hormone receptor positive breast cancer-from mechanism to therapy","volume":"10","author":"Rani","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bbadis.2026.168266_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102670","article-title":"Current and emerging treatment approaches for hormone receptor-positive\/human epidermal growth factor receptor 2-negative metastatic breast cancer","volume":"123","author":"Jhaveri","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbadis.2026.168266_bb0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1200\/JCO.2024.42.16_suppl.1069","article-title":"Elacestrant in various combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative (HER2-) locally advanced or metastatic breast cancer (adv\/mBC): preliminary data from ELEVATE, a phase 1b\/2, open-label, umbrella study","volume":"42","author":"Rugo","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0040","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0045","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1200\/JCO.24.00248","article-title":"Endocrine and targeted therapy for hormone receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative metastatic breast cancer\u2014capivasertib-fulvestrant: ASCO rapid recommendation update","volume":"42","author":"Burstein","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2026.168266_bb0050","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0960-9776(19)31118-X","article-title":"Endocrine therapy resistance: new insights","volume":"48","author":"Lei","year":"2019","journal-title":"Breast (Edinburgh, Scotland)"},{"key":"10.1016\/j.bbadis.2026.168266_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13058-025-01965-3","article-title":"CXCR4 promotes tumor stemness maintenance and CDK4\/6 inhibitors resistance in ER-positive breast cancer","volume":"27","author":"Shi","year":"2025","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0060","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0065","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164227","article-title":"Single-cell analysis of breast cancer metastasis reveals epithelial-mesenchymal plasticity signatures associated with poor outcomes","volume":"134","author":"Winkler","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2026.168266_bb0070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-020-00235-2","article-title":"Regulation of cancer cell metabolism: oncogenic MYC in the driver\u2019s seat","volume":"5","author":"Dong","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168266_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","article-title":"The ins and outs of serine and glycine metabolism in cancer","volume":"3","author":"Geeraerts","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.bbadis.2026.168266_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13046-017-0648-4","article-title":"PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3beta\/beta-catenin\/cyclin D1 signaling pathway in ER-negative breast cancer","volume":"36","author":"Gao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0085","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1158\/0008-5472.CAN-05-0064","article-title":"Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer","volume":"65","author":"Martens","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0090","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41598-017-02296-w","article-title":"Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer","volume":"7","author":"De Marchi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168266_bb0095","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10585-019-10000-7","article-title":"Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer","volume":"37","author":"Metcalf","year":"2020","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.bbadis.2026.168266_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/ERC-19-0510","article-title":"Serine synthesis influences tamoxifen response in ER+ human breast carcinoma","volume":"28","author":"Metcalf","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0105","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","article-title":"HNRNPA2B1 is a mediator of m6A-dependent nuclear RNA processing events","volume":"162","author":"Alarc\u00f3n","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168266_bb0110","doi-asserted-by":"crossref","first-page":"9430","DOI":"10.1038\/s41598-019-45636-8","article-title":"HNRNPA2\/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells","volume":"9","author":"Klinge","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168266_bb0115","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.18632\/aging.204992","article-title":"HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration","volume":"15","author":"Ayoufu","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.bbadis.2026.168266_bb0120","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/biology10080712","article-title":"hnRNP A\/B proteins: an encyclopedic assessment of their roles in homeostasis and disease","volume":"10","author":"Thibault","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.bbadis.2026.168266_bb0125","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2021.07.015","article-title":"HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells","volume":"518","author":"Petri","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbadis.2026.168266_bb0130","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0148","article-title":"MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells","volume":"30","author":"Petri","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129607","article-title":"A comprehensive review on signaling attributes of serine and serine metabolism in health and disease","volume":"260","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0140","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/s41388-024-03122-0","article-title":"The methionine cycle and its cancer implications","volume":"43","author":"Tassinari","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168266_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcae009","article-title":"METTL3 as a master regulator of translation in cancer: mechanisms and implications","volume":"6","author":"Esteva-Socias","year":"2024","journal-title":"NAR Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0150","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/1873-3468.13107","article-title":"Adenosine methylation as a molecular imprint defining the fate of RNA","volume":"592","author":"Knuckles","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2026.168266_bb0155","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0110","article-title":"m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer","volume":"70","author":"Petri","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0160","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20230574","article-title":"RNA m6A modification, signals for degradation or stabilisation?","volume":"52","author":"Wei","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbadis.2026.168266_bb0165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41416-023-02275-1","article-title":"RNA modifications in cancer","volume":"129","author":"Tang","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008604","article-title":"Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis","volume":"5","author":"Crawford","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.bbadis.2026.168266_bb0175","first-page":"3486","article-title":"MCF7\/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen","volume":"57","author":"Brunner","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0180","first-page":"1904","article-title":"Use of two MCF-7 cell variants to evaluate the growth regulatory potential of estrogen-induced products","volume":"46","author":"Davidson","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymeth.2007.09.006","article-title":"Real-time PCR quantification of precursor and mature microRNA","volume":"44","author":"Schmittgen","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.bbadis.2026.168266_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114686","article-title":"Polychlorinated biphenyls alter hepatic m6A mRNA methylation in a mouse model of environmental liver disease","volume":"216","author":"Petri","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0195","article-title":"Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver","volume":"7","author":"Klinge","year":"2021","journal-title":"Environ. Epigenetics"},{"key":"10.1016\/j.bbadis.2026.168266_bb0200","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1021\/ac2017025","article-title":"MetSign: a computational platform for high-resolution mass spectrometry-based metabolomics","volume":"83","author":"Wei","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbadis.2026.168266_bb0205","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1021\/ac3016856","article-title":"Data Preprocessing Method for Liquid Chromatography\u2013Mass Spectrometry Based Metabolomics","volume":"84","author":"Wei","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbadis.2026.168266_bb0210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/plants8050110","article-title":"Preliminary automated determination of edibility of alternative foods: non-targeted screening for toxins in red maple leaf concentrate","volume":"8","author":"Pearce","year":"2019","journal-title":"Plants"},{"key":"10.1016\/j.bbadis.2026.168266_bb0215","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-25-0174","article-title":"Targeting METTL3 induces a metabolic vulnerability in ER+ breast carcinoma cells","volume":"32","author":"Sumlut","year":"2025","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41388-023-02602-z","article-title":"METTL3 regulates breast cancer-associated alternative splicing switches","volume":"42","author":"Achour","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168266_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.yexcr.2016.08.006","article-title":"Nuclear respiratory factor-1 and bioenergetics in tamoxifen-resistant breast cancer cells","volume":"347","author":"Radde","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.114686","article-title":"Polychlorinated biphenyls alter hepatic m6A mRNA methylation in a mouse model of environmental liver disease","volume":"216","author":"Petri","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0240","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/s12276-024-01235-w","article-title":"The m6A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism","volume":"56","author":"Park","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168266_bb0245","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","article-title":"N6-Methyladenosine modification activates the serine synthesis pathway to mediate therapeutic resistance in liver cancer","volume":"32","author":"Chan","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2026.168266_bb0250","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-methyladenosine marks primary microRNAs for processing","volume":"519","author":"Alarc\u00f3n","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168266_bb0255","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gkab297","article-title":"miRTargetLink 2.0\u2014interactive miRNA target gene and target pathway networks","volume":"49","author":"Kern","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0260","doi-asserted-by":"crossref","first-page":"8640","DOI":"10.1038\/s41598-019-44714-1","article-title":"Functional roles of hnRNPA2\/B1 regulated by METTL3 in mammalian embryonic development","volume":"9","author":"Kwon","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168266_bb0265","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41594-021-00606-5","article-title":"Mining for METTL3 inhibitors to suppress cancer","volume":"28","author":"Li","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0270","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molcel.2016.05.041","article-title":"Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases","volume":"63","author":"Wang","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2026.168266_bb0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13148-024-01628-8","article-title":"METTL3 promotes osteoblast ribosome biogenesis and alleviates periodontitis","volume":"16","author":"Zhang","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbadis.2026.168266_bb0280","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10142-025-01658-2","article-title":"Integrated Nanopore and short-read RNA sequencing identifies dysregulation of METTL3- m6A modifications in endocrine therapy- sensitive and resistant breast cancer cells","volume":"25","author":"Petri","year":"2025","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.bbadis.2026.168266_bb0285","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cac2.12509","article-title":"Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3","volume":"44","author":"Cesaro","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bbadis.2026.168266_bb0290","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jpha.2023.04.009","article-title":"Effects and translatomics characteristics of a small-molecule inhibitor of METTL3 against non-small cell lung cancer","volume":"13","author":"Xiao","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bbadis.2026.168266_bb0295","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.chembiol.2023.09.001","article-title":"Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy","volume":"31","author":"Yu","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0300","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41388-023-02602-z","article-title":"METTL3 regulates breast cancer-associated alternative splicing switches","volume":"42","author":"Achour","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168266_bb0305","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1741","article-title":"The biochemical basis of microRNA targeting efficacy","volume":"366","author":"McGeary","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2026.168266_bb0310","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0315","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajpath.2019.11.013","article-title":"Inflammation and DNA Methylation\u2013Dependent Down-Regulation of miR-34b-5p Mediates c-MYC Expression and CRL4DCAF4 E3 Ligase Activity in Colitis-Associated Cancer","volume":"190","author":"Yang","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0320","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","article-title":"p53 represses c-Myc through induction of the tumor suppressor miR-145","volume":"106","author":"Sachdeva","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbadis.2026.168266_bb0325","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature12986","article-title":"The multilayered complexity of ceRNA crosstalk and competition","volume":"505","author":"Tay","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168266_bb0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-024-02503-y","article-title":"The role of ceRNAs in breast cancer microenvironmental regulation and therapeutic implications","volume":"103","author":"Yilmaz","year":"2025","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168266_bb0335","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1158\/1078-0432.CCR-03-0538","article-title":"Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial","volume":"10","author":"Kisanga","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168266_bb0340","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1038\/s41388-025-03494-x","article-title":"Steroid receptor coactivator-1 facilitates METTL3-mediated m6A modification by coactivating NF-\u03baB and promotes the malignant progression of glioblastoma","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168266_bb0345","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/s41419-021-04169-7","article-title":"New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia","volume":"12","author":"Ianniello","year":"2021","journal-title":"Cell Death Dis."},{"issue":"Part 3","key":"10.1016\/j.bbadis.2026.168266_bb0350","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.mce.2015.09.035","article-title":"Endocrine resistance in breast cancer \u2013 an overview and update","volume":"418","author":"Clarke","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1083048","article-title":"The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness","volume":"14","author":"Andrade de Oliveira","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0360","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2026.168266_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110278","article-title":"Lineage-specific silencing of PSAT1 induces serine auxotrophy and sensitivity to dietary serine starvation in luminal breast tumors","volume":"38","author":"Choi","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbadis.2026.168266_bb0370","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168266_bb0375","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13000-024-01556-4","article-title":"PSAT1 is upregulated by METTL3 to attenuate high glucose-induced retinal pigment epithelial cell apoptosis and oxidative stress","volume":"19","author":"Du","year":"2024","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","article-title":"Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbadis.2026.168266_bb0385","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.7150\/jca.42338","article-title":"The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation","volume":"11","author":"Yuan","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.12.009","article-title":"Fine-tuning of gene expression through the Mettl3-Mettl14-Dnmt1 axis controls ESC differentiation","volume":"188","author":"Quarto","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168266_bb0395","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41467-025-58966-1","article-title":"m6A\/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168266_bb0400","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/ijc.35067","article-title":"The m6A-independent role of epitranscriptomic factors in cancer","volume":"155","author":"Bove","year":"2024","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbadis.2026.168266_bb0405","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s41388-023-02617-6","article-title":"METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation","volume":"42","author":"Bhattarai","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168266_bb0410","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13148-024-01729-4","article-title":"Epitranscriptomics and epigenetics: two sides of the same coin?","volume":"16","author":"Bove","year":"2024","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.bbadis.2026.168266_bb0415","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/cmb.2010.0038","article-title":"DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells","volume":"18","author":"Kuo","year":"2011","journal-title":"J. Comput. Biol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0420","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.bbadis.2026.168266_bb0425","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107333","article-title":"A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast","volume":"40","author":"Pal","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2026.168266_bb0430","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13073-024-01407-3","article-title":"Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer","volume":"16","author":"Fang","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.bbadis.2026.168266_bb0435","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10555-020-09905-7","article-title":"Regulation of breast cancer metastasis signaling by miRNAs","volume":"39","author":"Petri","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bbadis.2026.168266_bb0440","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41419-021-03868-5","article-title":"Interactions between m6A modification and miRNAs in malignant tumors","volume":"12","author":"Han","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168266_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010773","article-title":"Emerging mutual regulatory roles between m(6)A modification and microRNAs","volume":"24","author":"Mei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168266_bb0450","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1074\/jbc.M116.749689","article-title":"MicroRNA-145 modulates N6-methyladenosine levels by targeting the 3\u2032-untranslated mRNA region of the N6-methyladenosine binding YTH domain family 2 protein","volume":"292","author":"Yang","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168266_bb0455","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1261\/rna.079988.124","article-title":"Understanding the redundant functions of the m6A-binding YTHDF proteins","volume":"30","author":"Zaccara","year":"2024","journal-title":"RNA"},{"key":"10.1016\/j.bbadis.2026.168266_bb0460","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.7150\/ijbs.92413","article-title":"N6-methyladenosine modification of LATS2 promotes hepatoblastoma progression by inhibiting ferroptosis through the YAP1\/ATF4\/PSAT1 axis","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2026.168266_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.06.014","article-title":"Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer","volume":"81","author":"Einstein","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbadis.2026.168266_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104271","article-title":"RNA-binding proteins in breast cancer: biological implications and therapeutic opportunities","volume":"195","author":"Wang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1618","article-title":"A birds'-eye view of the activity and specificity of the mRNA m6A methyltransferase complex","volume":"12","author":"Garcias Morales","year":"2021","journal-title":"WIREs RNA"},{"key":"10.1016\/j.bbadis.2026.168266_bb0480","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12672-025-02644-7","article-title":"Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential","volume":"16","author":"Shen","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.604597","article-title":"Expression and prognostic characteristics of m6 A RNA methylation regulators in breast cancer","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbadis.2026.168266_bb0490","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-025-00857-w","article-title":"Decoding the interactions and functions of non-coding RNA with artificial intelligence","volume":"26","author":"Jung","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168266_bb0495","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.tox.2011.10.016","article-title":"S-Adenosylhomocysteine enhances DNA damage through increased \u03b2-amyloid formation and inhibition of the DNA-repair enzyme OGG1b in microglial BV-2 cells","volume":"290","author":"Lin","year":"2011","journal-title":"Toxicology"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926001298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T20:20:47Z","timestamp":1780172447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926001298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0925443926001298"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168266","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168266"}}